Johnson & Johnson told to pay $2.1 billion over Cancer-Causing powder


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Johnson & Johnson told to pay $2.1 billion over Cancer-Causing powder
Johnson & Johnson has faced thousands of lawsuits across the US alleging it failed to warn consumers of the risk of cancer from asbestos in its talc-based

A US court has maintained a decision that bath powder sold by Johnson and Johnson caused ovarian malignancy and requested the pharmaceutical goliath to pay $2.1 billion in harms.

The choice by the Missouri Court of Appeals cut by the greater part the $4.4 billion a jury had granted 22 individuals in 2018. The court concurred that a portion of the complainants ought not to have been remembered for the case as they were from outside the state.

In any case, the Tuesday choice maintained the granting of harms for the organization "intentionally selling items that contained asbestos to buyers."

"Since litigants are huge, multi-billion-dollar enterprises, we accept a lot of corrective harms is important to have an impact on this situation," the judgment said.

"It is difficult to put money related an incentive on the physical, mental, and enthusiastic anguish objections endured as a result of their physical issue brought about by litigants."

A representative for Johnson and Johnson said the organization would bid the choice in the Supreme Court of Missouri, as per the Wall Street Journal.

Johnson and Johnson have confronted a great many claims over the United States asserting it neglected to caution buyers of the danger of malignancy from asbestos in its powder-based items.

In 2019 a California jury turned into the most recent to grant millions in harm to a grievance who said the organization's child powder had given her terminal malignant growth.

A month ago the firm declared it was suspending the creation of its powder-based child powder in the US and Canada, to some degree due to the "steady flood of case publicizing" over the item.

It will keep on selling the item in the remainder of the world, it included.

Tags : #JohnsonJohnson #Cancer #21billion

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026